Policy & Regulation
-
FDA Proposes Ban on Brominated Vegetable Oil Due to Health Risks
2024-01-11The Food and Drug Administration (FDA) has recently proposed a ban on the use of brominated vegetable oil (BVO), a food ingredient commonly found in certain beverages like Gatorade and Mountain Dew.
-
AiolosBio: The Middleman with an Eye for Opportunity in the Pharmaceutical Industry?
2024-01-10On January 9, pharmaceutical giant GlaxoSmithKline (GSK) announced its acquisition agreement with AiolosBio, a move aimed at strengthening its portfolio in the respiratory and inflammation drug market.
-
Can Lecanemab Revolutionize Alzheimer's Disease Treatment?
2024-01-10Alzheimer's disease (AD) poses a significant challenge worldwide, affecting millions of individuals and their families. However, a breakthrough may be on the horizon with the recent approval of Lecanemab-irmb, a novel drug developed by Eisai
-
Study Finds Semaglutide Lower Suicide Ideation Risk Compared to Other Diabetes and Obesity Medications
2024-01-10According to a new federally-funded study by the National Institutes of Health, the drugs semaglutide, commonly used to treat diabetes and obesity, have been found to reduce the risk of suicide ideation in patients compared to other medications used for t
-
Can Florida's Authorization to Import Prescription Drugs from Canada Lower Medication Prices?
2024-01-08In a groundbreaking move, the U.S. Food and Drug Administration (FDA) has granted Florida permission to directly import prescription drugs from Canada.
-
Is FDA Doing Enough to Ensure the Safety of Food Additives?
2024-01-08In a closely-watched development, California legislators recently passed a bill that could ban the sale of certain food additives in the state.
-
Announcement: ECHEMI Data Upgrade Notice
2024-01-04The ECHEMI data server will be upgraded. After the upgrade, the stability and data timeliness in 2024 can be significantly improved.
-
Are GLP-1 Receptor Agonists Linked to Hair Loss and Suicidal Thoughts?
2024-01-04The US Food and Drug Administration (FDA) is closely examining reports of potential side effects associated with certain medications like Ozempic, Mounjaro, and Wegovy.
-
Medytox Establishes U.S. Subsidiary to Expand BTX Market’s Global Reach
2024-01-03Meditox, a Korean botulinum toxin (BTX) manufacturer, said it has established a U.S. subsidiary, Luvantas, to enter the global market with its non-animal-derived liquid BTX preparation MT10109L.
-
Is Promethazine Hydrochloride Injection Putting Patients at Risk? FDA Alerts Healthcare Professionals
2023-12-28Is Promethazine Hydrochloride Injection Putting Patients at Risk? FDA Alerts Healthcare Professionals.
-
Avoiding Misdiagnosis: The FDA's Warning on False Positive Results in Genital Herpes Testing
2023-12-28Could your genital herpes test results be misleading?
-
What Changes Does the Latest MFDS Announcement Bring to South Korea's Functional Food Regulations?
2023-12-27The South Korean Ministry of Food and Drug Safety (MFDS) has recently issued Notice No. 2023-91, introducing amendments to certain provisions of the "Health Functional Food Code."
-
Can New Entrants Succeed in the Competitive GLP-1 Drug Market?
2023-12-27The expanding potential of GLP-1 drugs has attracted significant attention from pharmaceutical companies worldwide. Analysts predict that annual sales of GLP-1-related drugs could exceed $100 billion by 2030, creating a highly lucrative market.
-
Is Switzerland Strengthening Food Safety Regulations with Revised Processing Food Regulations?
2023-12-26The question arises: Is Switzerland strengthening food safety regulations with the revised processing food regulations? The revised regulations indeed demonstrate Switzerland's commitment to enhancing food safety measures.
-
New EPA Regulation Sets Temporary Maximum Residue Limits for Kasugamycin in Selected Products
2023-12-20The United States Environmental Protection Agency (EPA) recently issued Regulation No. 2023-27654 on December 18, 2023.
-
The Rise of biological linecides: Saving hundreds of billions of dollars in crop losses caused by nematodes
2023-12-18The Rise of biological linecides: Saving hundreds of billions of dollars in crop losses caused by nematodes
-
China's Active Pharmaceutical Ingredients Industry Analysis - Driving China's Pharmaceutical Industry: Unveiling the Power of National Policies
2023-12-15China's pharmaceutical industry is experiencing a transformative period driven by strategic national policies aimed at fostering high-quality development, enhancing production standards, and promoting environmental sustainability.
-
Setbacks in Cell Therapy: FDA Halts Clinical Trials of Three Biotech's Products
2023-12-15Biotech company SciGene Pharmaceuticals, specializing in cell therapy, revealed that it had received a notice from the U.S. Food and Drug Administration (FDA) on the previous day, ordering the temporary halt of clinical trials for its products CT053, CT04
-
Sirona Biochem Corp to Trademark Anti-aging Molecule as GlycoProteMim
2023-12-13Sirona Biochem has begun the trademarking process through it’s subsidiary, TFChem and is engaging industry experts to plan for commercializing GlycoProteMim.
-
Crystal India acquips Syngenta's herbicide Gramoxone(Paraquat)trademark for use in its market
2023-12-12Crystal India recently announced the acquisition of the herbicide Gramoxone (active ingredient: Paraquat) trademark from Syngenta for use in the Indian market.
Hot News
-
ECHEMI平台投诉处罚规则 - ECHEMI platform complaint penalty rules
-
ECHEMI平台禁限售商品目录规则 - Announcement on the list of prohibited sales of Prohibited and Controlled Items on ECHEMI
-
ECHEMI禁售商品发布规则 Rules for the Release of Prohibited Products on ECHEMI.com
-
From August 1st, many shipping companies charge high port congestion fees!
-
Congestion in 116 ports around the world! The increase in freight rates will continue into the first half of next year!
-
Semaglutide initiates Phase III clinical trial of NASH in China
-
GLP-1 competition: Semaglutide surpasses dulaglutide this year
-
GlaxoSmithKline Pharmaceuticals Reports 11% Rise in Q1 Profit Driven by Strong Demand for Vaccines
-
Ecuador pesticides market: imports during 2022 reached 275.6 Mio USD and 53.5 Mio USD in Q1 2023
-
Styrene: Supply And Demand Change